Immuneering Corporation Basic Shares Outstanding (Weighted Average)
Immuneering Corporation (IMRX) reported Basic Shares Outstanding (Weighted Average) of 64.70 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-05
- Immuneering Corporation weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 64.70M shares, a 79.79% increase year-over-year.
- Immuneering Corporation weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 64.66M shares, a 81.99% increase year-over-year.
- Immuneering Corporation weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 64.82M shares, a 108.69% increase year-over-year.
- Immuneering Corporation weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 39.67M shares, a 32.93% increase year-over-year.
- Immuneering Corporation weighted average number of shares outstanding, basic for fiscal 2025 was 44.01M shares, a 46.80% increase from fiscal 2024.
- Immuneering Corporation weighted average number of shares outstanding, basic for fiscal 2024 was 29.98M shares, a 5.51% increase from fiscal 2023.
- Immuneering Corporation weighted average number of shares outstanding, basic for fiscal 2023 was 28.42M shares, a 7.69% increase from fiscal 2022.
- Immuneering Corporation weighted average number of shares outstanding, basic for fiscal 2022 was 26.39M shares, a 93.84% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 64.70M shares 10-Q · filed 2026-08-05 | 64.68M shares 10-Q · filed 2026-08-05 | 64.72M shares derived: average of 3 quarters · filed 2026-08-05 | 58.46M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | 64.66M shares 10-Q · filed 2026-05-15 | 64.74M shares derived: average of 2 quarters · filed 2026-05-15 | 56.38M shares derived: average of 3 quarters · filed 2026-05-15 | 51.28M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | 64.82M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | 52.24M shares derived: average of 2 quarters · filed 2026-03-06 | 46.82M shares derived: average of 3 quarters · filed 2026-08-05 | 44.01M shares 10-K · filed 2026-03-06 |
| 2025-09-30 | 39.67M shares 10-Q · filed 2025-11-12 | 37.83M shares derived: average of 2 quarters · filed 2026-08-05 | 37.08M shares 10-Q · filed 2025-11-12 | 35.56M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | 35.99M shares 10-Q · filed 2026-08-05 | 35.76M shares 10-Q · filed 2026-08-05 | 34.19M shares derived: average of 3 quarters · filed 2026-08-05 | 33.10M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | 35.53M shares 10-Q · filed 2026-05-15 | 33.29M shares derived: average of 2 quarters · filed 2026-05-15 | 32.14M shares derived: average of 3 quarters · filed 2026-05-15 | 31.52M shares derived: average of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | 31.06M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | 30.45M shares derived: average of 2 quarters · filed 2026-03-06 | 30.18M shares derived: average of 3 quarters · filed 2026-03-06 | 29.98M shares 10-K · filed 2026-03-06 |
| 2024-09-30 | 29.84M shares 10-Q · filed 2025-11-12 | 29.75M shares derived: average of 2 quarters · filed 2025-11-12 | 29.62M shares 10-Q · filed 2025-11-12 | 29.54M shares derived: average of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | 29.65M shares 10-Q · filed 2025-08-13 | 29.51M shares 10-Q · filed 2025-08-13 | 29.43M shares derived: average of 3 quarters · filed 2025-08-13 | 29.39M shares derived: average of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | 29.37M shares 10-Q · filed 2025-05-05 | 29.32M shares derived: average of 2 quarters · filed 2025-05-05 | 29.31M shares derived: average of 3 quarters · filed 2025-05-05 | 29.14M shares derived: average of 4 quarters · filed 2025-05-05 |
| 2023-12-31 | 29.28M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | 29.27M shares derived: average of 2 quarters · filed 2025-03-20 | 29.06M shares derived: average of 3 quarters · filed 2025-03-20 | 28.42M shares 10-K · filed 2025-03-20 |
| 2023-09-30 | 29.27M shares 10-Q · filed 2024-11-13 | 28.96M shares derived: average of 2 quarters · filed 2024-11-13 | 28.13M shares 10-Q · filed 2024-11-13 | 27.69M shares derived: average of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | 28.65M shares 10-Q · filed 2024-08-06 | 27.55M shares 10-Q · filed 2024-08-06 | 27.17M shares derived: average of 3 quarters · filed 2024-08-06 | 26.97M shares derived: average of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | 26.44M shares 10-Q · filed 2024-05-07 | 26.42M shares derived: average of 2 quarters · filed 2024-05-07 | 26.41M shares derived: average of 3 quarters · filed 2024-05-07 | 26.41M shares derived: average of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | 26.41M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | 26.40M shares derived: average of 2 quarters · filed 2024-03-01 | 26.40M shares derived: average of 3 quarters · filed 2024-03-01 | 26.39M shares 10-K · filed 2024-03-01 |
| 2022-09-30 | 26.39M shares 10-Q · filed 2023-11-09 | 26.39M shares derived: average of 2 quarters · filed 2023-11-09 | 26.38M shares 10-Q · filed 2023-11-09 | 26.31M shares derived: average of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | 26.39M shares 10-Q · filed 2023-08-03 | 26.37M shares 10-Q · filed 2023-08-03 | 26.29M shares derived: average of 3 quarters · filed 2023-08-03 | 24.29M shares derived: average of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | 26.36M shares 10-Q · filed 2023-05-04 | 26.24M shares derived: average of 2 quarters · filed 2023-05-04 | 23.59M shares derived: average of 3 quarters · filed 2023-05-04 | 18.93M shares derived: average of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | 26.11M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | 22.20M shares derived: average of 2 quarters · filed 2023-03-06 | 16.45M shares derived: average of 3 quarters · filed 2023-03-06 | 13.61M shares 10-K · filed 2023-03-06 |
| 2021-09-30 | 18.29M shares 10-Q · filed 2022-11-10 | 11.62M shares derived: average of 2 quarters · filed 2022-11-10 | 9.45M shares 10-Q · filed 2022-11-10 | 8.29M shares derived: average of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | 4.95M shares 10-Q · filed 2022-08-10 | 4.95M shares 10-Q · filed 2022-08-10 | 4.95M shares derived: average of 3 quarters · filed 2022-08-10 | 4.95M shares derived: average of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | 4.95M shares 10-Q · filed 2022-05-10 | 4.95M shares derived: average of 2 quarters · filed 2022-05-10 | 4.95M shares derived: average of 3 quarters · filed 2022-05-10 | 4.95M shares derived: average of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | 4.95M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | 4.95M shares derived: average of 2 quarters · filed 2022-03-10 | 4.95M shares derived: average of 3 quarters · filed 2022-03-10 | 4.95M shares 10-K · filed 2022-03-10 |
| 2020-09-30 | 4.95M shares 10-Q · filed 2021-11-09 | 4.95M shares derived: average of 2 quarters · filed 2021-11-09 | 4.95M shares 10-Q · filed 2021-11-09 | |
| 2020-06-30 | 4.95M shares 10-Q · filed 2021-09-09 | 4.95M shares 10-Q · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |